ALDH5A1
ALDH5A1 (aldehyde dehydrogenase 5 family member A1, also known as SSADH or SSDH) is a mitochondrial NAD(+)-dependent succinic semialdehyde dehydrogenase. It catalyses one step in the degradation of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). Browse Assay Genie's current range of ALDH5A1 research reagents below, or read on for the biology behind the target.
ALDH5A1 is a mitochondrial succinate-semialdehyde dehydrogenase that depends on NAD(+) as a cofactor. Its recorded function is to catalyse one step in the breakdown of gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter. Because the enzyme sits in this degradative route, it is a natural focus for studies of GABA turnover and neurotransmitter metabolism. Researchers looking for an ALDH5A1 antibody, an ALDH5A1 ELISA kit or recombinant ALDH5A1 protein typically do so to examine this role in the mitochondrion.
The ALDH5A1 gene encodes a protein that belongs to the aldehyde dehydrogenase family, and HGNC places it in the aldehyde dehydrogenases gene group. The previous name of the gene was aldehyde dehydrogenase 5 family, member A1, and the protein is also referred to as SSADH or SSDH. NCBI Gene reports two transcript variants that encode distinct isoforms. Mouse and rat both carry an orthologous gene, Aldh5a1, which allows the enzyme to be studied in common model organisms.
A deficiency of this enzyme is known as 4-hydroxybutyricaciduria, a rare inborn error in the metabolism of 4-aminobutyric acid (GABA). In response to the defect, physiological fluids from patients accumulate GHB, a compound with numerous neuromodulatory properties. This link makes ALDH5A1 relevant to research on inherited metabolic disorders and on how disturbed GABA catabolism affects neurotransmission.
ALDH5A1 catalyses one step in the degradation of the inhibitory neurotransmitter GABA, making it central to studies of GABA catabolism.
Deficiency of this enzyme causes 4-hydroxybutyricaciduria, a rare inherited disorder of GABA metabolism.
Patients with enzyme deficiency accumulate GHB, a compound with numerous neuromodulatory properties, which links ALDH5A1 to neuromodulator studies.
As a mitochondrial NAD(+)-dependent member of the aldehyde dehydrogenase family, ALDH5A1 is useful for comparing enzyme function across the family.
ALDH5A1 encodes a mitochondrial NAD(+)-dependent succinic semialdehyde dehydrogenase. It catalyses one step in the degradation of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). Loss of the enzyme disturbs GABA metabolism and leads to accumulation of GHB.
ALDH5A1 is also called SSADH or SSDH, and its UniProt name is succinate-semialdehyde dehydrogenase, mitochondrial. The earlier gene name was aldehyde dehydrogenase 5 family, member A1. NCBI Gene reports two transcript variants encoding distinct isoforms.
Yes. Deficiency of the enzyme is known as 4-hydroxybutyricaciduria, a rare inborn error of GABA metabolism. Orthologous genes named Aldh5a1 exist in mouse and rat, so rodent models can be used. Check the datasheet of any product for its validated reactivity.
Other members of the aldehyde dehydrogenase family with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P51649; product specifications from Assay Genie datasheets.